Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	87.23	139.78	74.65
Graham Fair Price	-12.10	18.86	21.46
PEG	-37.05	-1.74	2.76
Price/Book	1.29	5.01	4.94
Price/Cash Flow	270.80	310.00	83.60
Prices/Earnings	32.51	39.67	29.94
Price/Sales	4.67	19.51	18.64
Price/FCF	270.80	310.00	83.60
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.37	0.56	0.51
Operating Margin	-20.05	0.15	0.18
ROA	-22.36	0.02	0.02
ROE	0.04	0.03	-23.56
ROIC	0.03	0.02	-25.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	0.02	264.94
Dividends QOQ	< 0.005	0.08	2814.21
EBIT QOQ	0.05	-0.22	313.58
EPS QOQ	0.11	-0.23	110.51
FCF QOQ	0.73	-0.73	-1.11
Revenue QOQ	< 0.005	-0.03	179.95
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	118.66	139.01	17.15
Days Sales Outstanding (DSO)	57.69	59.66	3.41
Inventory Turnover	0.76	0.65	-14.64
Debt/Capitalization	0.28	0.27	-2.03
Quick Ratio	1.00	0.95	-5.48
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	22.26	22.38	0.54
Cash	4.20	3.84	-8.63
Capex	-0.44	-0.23	47.28
Free Cash Flow	1.32	0.36	-72.54
Revenue	5.91	5.75	-2.70
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.64	1.60	-2.56
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.35	5.73	70.74
Naive Interpretation	Member

06 - Financial Health · Weak

Rating